Class Action Lawsuit Over Lipitor Reveals Potential Dangerous Side Effects
If you have been diagnosed with diabetes, then you may be eligible to receive compensation for past due medical bills and other damages by using the Lipitor class action lawsuit. The American Association of Clinical Endocrinologists (AACEA) developed the class action suit as a way to help people with diabetes to pay past due bills and keep their diabetes in check. If you have been diagnosed with diabetes, then you should contact an attorney quickly to start receiving past due compensation. The lawsuits are in favor of the patients and will give support during income replacement therapy, prescription management, and adjustment services.
Lipitor Class Action Lawsuit
When you have been diagnosed, it is important to immediately contact an experienced Lipitor attorney to discuss your case. The legal professionals at O Connor, Acciani & Levy can assist you with working with the local district judge. The attorneys will advise you if you qualify to proceed with the lawsuit. If you have been diagnosed with Diabetes, the Lipitor attorneys at Acciani & Levitt can assist you with working with the local district judge and filing a complaint to hold the manufacturers of the defective drugs responsible for medical malpractice.
Lipitor attorneys are familiar with all the details regarding this type of class action lawsuit. They know what to expect and how to prepare their clients for the court proceedings. These experienced attorneys have many years of experience successfully representing people with all types of medical conditions including type 2 diabetes. This is one reason why the Lipitor attorneys are qualified to represent you in court.
The Lipitor class-action lawsuit was designed to address the issue of Atorvastatin’s propensity to cause harm to patients with type-2 diabetes. The Food and Drug Administration approved the use of Atorvastatin, a cholesterol-lowering drug, in June 2021. Subsequently, Atorvastatin was approved by the European Medicines Agency in March 2021. However, the FDA failed to instruct healthcare companies how they could formulate replacement drugs for Atorvastatin, so these replacement drugs could not be marketed or advertised as of the time of this lawsuit’s discovery. The plaintiffs’ lawyers filed the class-action lawsuit on behalf of all patients who have been personally affected by Atorvastatin and its potentially harmful side effects.
In the United States, the Atorvastatin class action lawsuit has become something of a cottage industry. The lawsuits generally assert that the defendants did not disclose important information about the potential risks of Atorvastatin and did not warn patients about the potential side effects of taking the drug. Many of the plaintiffs in the lipitor lawsuit have been diagnosed with Type-2 diabetes, an incurable disease that often requires lifelong treatment. Many other plaintiffs are diagnosed with pre-diabetic conditions or obesity. Some plaintiffs are being treated with Atorvastatin to control their cholesterol levels as well as to treat their diabetes.
After reviewing the Atorvastatin class action lawsuit, the FDA decided to phase out the drug in February of this year, without taking any disciplinary action against the manufacturers, including Janssen Pharmaceuticals and GlaxoSmithKline. The FDA also announced that it is considering changing the name of the cholesterol-lowering medication atorvastatin to reduce confusion. According to the news media, the name change is “anticipated”. The FDA has not determined if the new name will be available before the end of this year or later. The class-action lawsuit asserts that Janssen neglected to inform patients that the medication atorvastatin can cause serious side effects, including heart attacks, strokes, and low blood pressure.
